Part-funded by Maudsley Charity, the £37 million Maurice Wohl Clinical Neuroscience Institute, located at King’s College Hospital in South London, is Europe’s leading research centre focusing on neurological and psychiatric illnesses.
Breaking down barriers to fast-track research and treatment
The Institute is a key research facility in efforts to fast-track new treatments to patients affected by disorders such as Alzheimer’s disease, Parkinson’s disease, motor neurone disease, depression, schizophrenia, epilepsy and stroke.
Maurice Wohl Clinical Neuroscience Institute – bringing experts together
Encouraging interaction and collaboration under one roof, it brings together more than 250 clinicians and scientists, dedicated to mental health and neurological research, who were previously working in separate departments and in dispersed locations.
It is estimated that one in three people will suffer from a psychiatric or neurological disorder in their lifetime. This 7,600m² development allows King’s College London (KCL), working as part of King’s Health Partners, to dramatically accelerate the translation of basic brain research into clinical practice.
At the heart of the Institute lies a network of patients, carers, clinicians and researchers, who all share a mission to help improve the lives of people who live with devastating and as yet incurable disorders. Part of this mission is to determine the underlying genetic and environmental risk factors for disease and to identify tests for early diagnosis and biomarkers that measure the progression of disease.
Thanks to donations, we’re able to continue to support people going through mental illness and recovery through a variety of innovative arts and community projects. Please help us to keep these projects running.